People · Operator
Named in public records as an officer, director or promoter · active 2011–2019 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Valentx Inc | — | Biotechnology | Series B | $40.0M | $78.2M | 2019 |
| Rapid Diagnostek, Inc. | — | Other Technology | Series A | $8.8M | $92.1M | 2012 |
| Regenesis Biomedical Inc | — | Biotechnology | Series A | $5.2M | $188.1M | 2011 |
Jack Ahrens at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jack Ahrens on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| PAUL LAVIOLETTE | 1 | 12 |
| James Wright | 1 | 9 |
| Daniel Einhorn | 1 | 7 |
| Charlie Goff | 1 | 4 |
| PAUL A. LAVIOLETTE | 1 | 3 |
| Henry Newman | 1 | 3 |
| Jon St. Germain | 1 | 2 |
| Brock Siegel | 1 | 2 |
| Mary L. Campbell | 1 | 2 |
| Bobby I Griffin | 1 | 2 |
| Bobby Griffin | 1 | 2 |
| Steve Einhorn | 1 | 2 |
| Edson W Spencer Jr | 1 | 2 |
| Elling Halvorson | 1 | 1 |
| Jon I. St. Germain | 1 | 1 |
| CHUCK LUNDEN | 1 | 1 |
| VIRGINIA RYBSKI | 1 | 1 |
| JOHN VORIS | 1 | 1 |
| PETER SHEEHAN | 1 | 1 |
| TOM GREER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.